Dauricine Mitigates Hypoxia through Targeting ESR1, PIK3CA, and MTOR: A Network Pharmacology and Molecular Dynamics Simulation Investigation
Preprint
- 5 May 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Hypoxia is a prevalent pathophysiological condition. Prolonged exposure to hypobaric hypoxia can lead to maladaptation, increasing the risk of chronic hypoxic diseases such as high-altitude polycythemia (HAPC). Dauricine, an alkaloid derived from the root of Menispermum dauricum DC, has been demonstrated to possess anti-hypoxic properties; however, its underlying molecular mechanisms remain elusive. In this study, a multi-target molecular mechanism of dauricine in mitigating hypoxia was systematically investigated using an integrated approach combining network pharmacology, molecular docking, and molecular dynamics simulations. Common targets between dauricine and hypoxia-related genes were identified through network pharmacology screening. A protein-protein interaction (PPI) network was constructed to identify core targets, followed by Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Molecular docking was subsequently employed to evaluate the binding affinities between dauricine and the core targets, while molecular dynamics simulations were performed to validate the stability of the resulting complexes. Additionally, the drug-likeness and safety profiles of dauricine were assessed. The results indicate that dauricine may exert its anti-hypoxic effects by modulating core targets, including ESR1, PIK3CA, and MTOR, and by acting on key signaling pathways such as PI3K-Akt, MAPK, and mTOR. This study provides a theoretical foundation for the development of dauricine as a multi-target candidate for intervention in hypoxia and establishes a bioinformatics basis for subsequent experimental validation.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Selenoprotein GPX3 regulates NADPH oxidase expression by inhibiting the MAPK signaling pathway and thereby attenuating the inflammatory response in renal ischemia-reperfusion injuryGenes & Diseases, 2026
- Identification of potential novel therapeutic drug target against Elizabethkingia anophelis by integrative pan and subtractive genomic analysis: An in silico approachComputers in Biology and Medicine, 2023
- Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additivesFood Chemistry, 2023
- Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formulaJournal of Ethnopharmacology, 2023
- iHypoxia: An Integrative Database of Protein Expression Dynamics in Response to Hypoxia in AnimalsGenomics, Proteomics & Bioinformatics, 2022
- Network pharmacology-based analysis of the anti-hyperglycemic active ingredients of roselle and experimental validationComputers in Biology and Medicine, 2022
- Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patientsJournal of Cancer Research and Clinical Oncology, 2017
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004